Product image of Letybo (Botulinum Toxin Type A) supplied by GNH India

Letybo

Active Ingredient:
Botulinum Toxin Type A
Origin:
EU

Letybo (Botulinum Toxin Type A)

Botulinum toxin type A, the active ingredient in Letybo, is a neuromuscular blocker presented as a sterile injectable for intramuscular use. It temporarily reduces muscle activity and is employed in therapeutic and aesthetic indications where localized muscle relaxation is required.

GNH India supplies Letybo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Croma Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Letybo, a botulinum toxin type A product, is used in several neuromuscular and cosmetic conditions where targeted muscle relaxation is needed.

  • Cervical dystonia: reduces abnormal neck muscle contractions and improves head posture.
  • Blepharospasm: relieves involuntary eyelid closure and associated discomfort.
  • Chronic migraine: decreases frequency of migraine days in adults with refractory migraine.
  • Upper‑limb spasticity: diminishes muscle tone to facilitate rehabilitation.
  • Hyperhidrosis: limits excessive sweating by blocking acetylcholine release in sweat glands.

How It Works

  • Botulinum toxin type A cleaves SNAP‑25, a protein essential for vesicle fusion, thereby blocking the release of acetylcholine at the neuromuscular junction. This inhibition prevents muscle fiber depolarisation, leading to a reversible, localized paralysis of the targeted muscle or glandular tissue.

Side Effects

Letybo may cause a range of adverse reactions following intramuscular injection.

Common Side Effects

  • Injection site pain or tenderness.
  • Bruising or erythema at the injection site.
  • Headache or flu‑like symptoms.
  • Localized muscle weakness.
  • Dry mouth.
  • Transient vision changes.

Serious or Rare Side Effects

  • Dysphagia or difficulty swallowing.
  • Respiratory compromise due to spread of toxin.
  • Generalised muscle weakness.
  • Anaphylactic reaction.
  • Systemic botulism‑like syndrome.
  • Persistent ptosis or eyelid droop.

Precautions & Warnings

Before using Letybo, clinicians should consider several safety measures.

  • Contraindication: Known hypersensitivity to botulinum toxin type A or any excipients.
  • Caution: Use in patients with neuromuscular disorders such as myasthenia gravis.
  • Pregnancy: Safety not established; prescribe only if potential benefit justifies risk.
  • Breastfeeding: Limited data; weigh benefits against potential infant exposure.
  • Interaction: Avoid concurrent use of other botulinum toxin products.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Botulinum toxin type A can interact with other agents that affect neuromuscular transmission.

Major Interactions (Avoid)

  • Aminoglycoside antibiotics (e.g., gentamicin): may potentiate neuromuscular blockade.
  • Non‑depolarising muscle relaxants (e.g., rocuronium): increased risk of profound weakness.
  • Quinine or quinidine: can enhance toxin effects.

Moderate Interactions (Monitor Closely)

  • Calcium channel blockers (e.g., verapamil): may alter muscle response.
  • Anticholinergic drugs: potential additive effect on muscle tone.
  • Other botulinum toxin preparations: risk of cumulative toxicity.

Frequently Asked Questions

Letybo contains botulinum toxin type A and is indicated for conditions that benefit from temporary muscle relaxation, such as cervical dystonia, blepharospasm, chronic migraine, upper‑limb spasticity, and severe hyperhidrosis.

The toxin cleaves the SNAP‑25 protein, preventing acetylcholine release at the neuromuscular junction. This blocks nerve‑muscle signalling, causing a reversible, localized paralysis of the injected muscle or gland.

Dosing of Letybo is individualized. The prescribing clinician determines the appropriate units and injection sites based on the specific indication, patient characteristics, and treatment goals.

Safety data for Letybo in pregnancy and lactation are limited. It should be used only if the potential therapeutic benefit justifies any possible risk to the fetus or infant, and after careful discussion with a healthcare professional.

To request Letybo, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Letybo is a botulinum toxin type A formulation similar in mechanism to other products such as Botox® or Dysport®. Differences may exist in unit potency, formulation excipients, and approved indications, which are evaluated by the prescribing clinician to select the most appropriate therapy.

Letybo must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until ready for use to maintain stability.

Letybo is supplied as a sterile injectable solution for intramuscular injection. A qualified healthcare professional injects the prescribed number of units into the targeted muscle or gland using aseptic technique.

Serious risks include dysphagia, respiratory compromise, generalized muscle weakness, anaphylaxis, and systemic botulism‑like syndrome. Prompt medical attention is required if any of these symptoms develop after treatment.

Letybo is contraindicated in individuals with known hypersensitivity to botulinum toxin type A or any formulation excipients, and should be used with caution in patients with neuromuscular disorders, active infection at the injection site, or those taking interacting medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Botulinum Toxin Type A

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT